{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005515","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2024-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.745854+00:00","generated_at":"2026-05-30T20:02:41.123336+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Edesa Biotech enters $3.87M ATM equity facility with H.C. Wainwright; terminates prior Canaccord agreement","bullets":["Entered ATM agreement with H.C. Wainwright to sell up to $3.87M common shares at market prices; commission 3%.","Terminated prior equity distribution agreement with Canaccord Genuity (dated March 2023) effective Oct 3, 2024.","Under the Canaccord agreement, Edesa sold ~368,309 shares for ~$2.0M proceeds; no termination penalties.","No obligation to sell all shares under the new ATM; company may suspend sales at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005515","json":"https://secwatch.observer/filing/0001171843-24-005515.json","markdown":"https://secwatch.observer/filing/0001171843-24-005515.md","text":"https://secwatch.observer/filing/0001171843-24-005515.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005515/0001171843-24-005515-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005515/f8k_100424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T20:02:41.123336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}